Method for the microbial production of 8-methyl nonanoic acid
US-10793881-B2 · Oct 6, 2020 · US
US11459591B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11459591-B2 |
| Application number | US-201716317844-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2017 |
| Priority date | Jul 19, 2016 |
| Publication date | Oct 4, 2022 |
| Grant date | Oct 4, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the production of capsaicinoid compounds including Capsaicin and Nonivamide via microbial fermentation.
Opening claim text (preview).
What is claimed is: 1. A method of producing a capsaicinoid glucoside of interest, said method comprising: providing a transformed microbe culture capable of expressing 1) an ACS enzyme having either a protein sequence similarity of at least 90% with SEQ ID NO: 1 and/or a DNA sequence similarity of at least 75% with SEQ ID NO: 3, 2) a CS enzyme having either a protein sequence similarity of at least 90% with SEQ ID NO: 2 and/or a DNA sequence similarity of at least 90% with SEQ ID NO: 4, and 3) a CaUGT2 enzyme having either a protein sequence similarity of at least 90% with SEQ ID NO: 6 and/or a DNA sequence similarity of at least 75% with SEQ ID NO: 5; incubating the transformed microbe culture to induce expression of the ACS enzyme, the CS enzyme, and the CaUGT2 enzyme; feeding a specific fatty acid precursor to said transformed microbe culture. 2. The method of claim 1 , wherein the capsaicinoid glucoside of interest is capsaicin-glucoside and the fatty acid precursor is 6E-8-methyl-6-nonenoic acid. 3. The method of claim 1 , wherein the capsaicinoid glucoside of interest is nonivamide-glucoside and the fatty acid precursor is nonanoic acid. 4. The method of claim 1 , wherein the transformed microbe culture is further capable of expressing an aminotransferase. 5. The method of claim 1 , wherein the transformed microbe culture is selected from the group consisting of yeast, non-capsaicinoid producing plants, algae and bacteria. 6. The method of claim 1 , wherein the transformed microbe culture is E. coli.
Hexosyltransferases (2.4.1) · CPC title
Natural spices, flavouring agents or condiments; Extracts thereof · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Ligases (6) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.